Prostate cancer in 2016: Improved outcomes and precision medicine come within reach

Nat Rev Urol. 2017 Feb;14(2):71-72. doi: 10.1038/nrurol.2016.270. Epub 2017 Jan 4.

Authors

Cora N Sternberg¹, Himisha Beltran²

Affiliations

¹ San Camillo and Forlanini Hospitals, Medical Oncology, Pavilion Flajani 1, Circonvallazione Gianicolense 87, Rome 00152, Italy.
² Weill Cornell Medical College, Division of Medical Oncology, 525 East 68th Street, Box 403, New York 10021, USA.

PMID: 28050016
DOI: 10.1038/nrurol.2016.270

No abstract available

Publication types

Review

MeSH terms

Biomarkers, Tumor / blood
Biomarkers, Tumor / genetics*
Clinical Trials as Topic / methods
Germ-Line Mutation / genetics*
Humans
Male
Precision Medicine / methods*
Precision Medicine / trends
Prostate-Specific Antigen / blood
Prostate-Specific Antigen / genetics
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / genetics*
Prostatic Neoplasms / therapy*
Treatment Outcome

Substances

Biomarkers, Tumor
Prostate-Specific Antigen